BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27666598)

  • 21. Antihypertensive medication and dementia risk in patients with hypertension: A nationwide population-based study.
    Lin CY; Chen PH; Tsai CL; Hsieh YW; Hu KC; Tsai FJ; Cho DY; Liao HY
    J Clin Neurosci; 2024 Jul; 125():83-94. PubMed ID: 38759352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and Mortality Associated with Cardiovascular Medication among Hypertensive COVID-19 Patients in South Korea.
    Oh TK; Cho HW; Suh JW; Song IA
    Yonsei Med J; 2021 Jul; 62(7):577-583. PubMed ID: 34164954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Balance Impairment with Risk of Incident Dementia among Older Adults.
    Kim HJ; Jeong S; Oh YH; Suh MJ
    J Prev Alzheimers Dis; 2024; 11(1):130-137. PubMed ID: 38230725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints.
    Hanon O; Pequignot R; Seux ML; Lenoir H; Bune A; Rigaud AS; Forette F; Girerd X
    J Hypertens; 2006 Oct; 24(10):2101-7. PubMed ID: 16957572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glomerular hyperfiltration is associated with dementia: A nationwide population-based study.
    Kang MW; Park S; Lee S; Lee Y; Cho S; Han K; Cho H; Kim Y; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(1):e0228361. PubMed ID: 31990949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the treatment of isolated systolic hypertension prevent dementia?
    Clarke CE
    J Hum Hypertens; 1999 Jun; 13(6):357-8; discussion 419-20. PubMed ID: 10408583
    [No Abstract]   [Full Text] [Related]  

  • 27. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.
    Ah YM; Lee JY; Choi YJ; Kim B; Choi KH; Kong J; Oh JM; Shin WG; Lee HY
    J Korean Med Sci; 2015 Dec; 30(12):1800-6. PubMed ID: 26713055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study.
    Raffaitin C; Gin H; Empana JP; Helmer C; Berr C; Tzourio C; Portet F; Dartigues JF; Alpérovitch A; Barberger-Gateau P
    Diabetes Care; 2009 Jan; 32(1):169-74. PubMed ID: 18945929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study.
    Hayden KM; Zandi PP; Lyketsos CG; Khachaturian AS; Bastian LA; Charoonruk G; Tschanz JT; Norton MC; Pieper CF; Munger RG; Breitner JC; Welsh-Bohmer KA;
    Alzheimer Dis Assoc Disord; 2006; 20(2):93-100. PubMed ID: 16772744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between dementia and ankylosing spondylitis: A nationwide, population-based, retrospective longitudinal cohort study.
    Jang HD; Park JS; Kim DW; Han K; Shin BJ; Lee JC; Choi SW; Suh SW; Yang JH; Park SY; Cho WJ; Hong JY
    PLoS One; 2019; 14(1):e0210335. PubMed ID: 30703142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of calcium channel blockers in patients with gastrointestinal disease in Japanese community pharmacies.
    Hamada A; Akiyoshi R; Ishii J; Hamada N; Miyazaki C; Hamada T; Ohwaki Y; Ikeda R; Wada M; Nakashima K
    J Clin Pharm Ther; 2012 Feb; 37(1):74-7. PubMed ID: 21395634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alcohol consumption and risk of dementia: the Rotterdam Study.
    Ruitenberg A; van Swieten JC; Witteman JC; Mehta KM; van Duijn CM; Hofman A; Breteler MM
    Lancet; 2002 Jan; 359(9303):281-6. PubMed ID: 11830193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical activity and dementia risk in the elderly: findings from a prospective Italian study.
    Ravaglia G; Forti P; Lucicesare A; Pisacane N; Rietti E; Bianchin M; Dalmonte E
    Neurology; 2008 May; 70(19 Pt 2):1786-94. PubMed ID: 18094335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD).
    Grimaldi-Bensouda L; Klungel O; Kurz X; de Groot MC; Maciel Afonso AS; de Bruin ML; Reynolds R; Rossignol M
    BMJ Open; 2016 Jan; 6(1):e009147. PubMed ID: 26747033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of the combination of amlodipine and candesartan in hypertensive patients with coronary artery disease: a subanalysis of the HIJ-CREATE study.
    Koyanagi R; Hagiwara N; Yamaguchi J; Kawada-Watanabe E; Haruta S; Takagi A; Ogawa H;
    J Cardiol; 2013 Oct; 62(4):217-23. PubMed ID: 23778009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotension receptor blockers reduce the risk of dementia.
    Chiu WC; Ho WC; Lin MH; Lee HH; Yeh YC; Wang JD; Chen PC;
    J Hypertens; 2014 Apr; 32(4):938-47. PubMed ID: 24406780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
    Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood Pressure Variability and the Risk of Dementia: A Nationwide Cohort Study.
    Yoo JE; Shin DW; Han K; Kim D; Lee SP; Jeong SM; Lee J; Kim S
    Hypertension; 2020 Apr; 75(4):982-990. PubMed ID: 32148122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium channel blockers are associated with lower gastric cancer risk: A territory-wide study with propensity score analysis.
    Li B; Cheung KS; Wong IY; Leung WK; Law S
    Int J Cancer; 2021 May; 148(9):2148-2157. PubMed ID: 33152125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.